Should I buy or sell Cardlytics stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cardlytics in the last twelve months. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" CDLX shares. View CDLX analyst ratings or view top-rated stocks .

What is Cardlytics' stock price target for 2024?

4 brokers have issued 1-year price objectives for Cardlytics' stock. Their CDLX share price targets range from $9.00 to $18.00. On average, they predict the company's stock price to reach $15.50 in the next twelve months. This suggests a possible upside of 27.3% from the stock's current price. View analysts price targets for CDLX or view top-rated stocks among Wall Street analysts .

How have CDLX shares performed in 2024?

Cardlytics' stock was trading at $9.21 at the beginning of the year. Since then, CDLX shares have increased by 32.2% and is now trading at $12.18. View the best growth stocks for 2024 here .

Are investors shorting Cardlytics?

Cardlytics saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 5,950,000 shares, an increase of 32.8% from the March 15th total of 4,480,000 shares. Based on an average daily trading volume, of 1,680,000 shares, the short-interest ratio is presently 3.5 days. View Cardlytics' Short Interest .

When is Cardlytics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024. View our CDLX earnings forecast .

How were Cardlytics' earnings last quarter?

Cardlytics, Inc. (NASDAQ:CDLX) posted its quarterly earnings data on Thursday, March, 14th. The company reported ($0.14) EPS for the quarter. The company earned $89.17 million during the quarter. Cardlytics had a negative net margin of 43.56% and a negative trailing twelve-month return on equity of 25.38%.

What ETF holds Cardlytics' stock?

Invesco Dorsey Wright Technology Momentum ETF holds 380,072 shares of CDLX stock, representing 1.38% of its portfolio.

What guidance has Cardlytics issued on next quarter's earnings?

Cardlytics updated its first quarter 2024 earnings guidance on Thursday, March, 14th. The company provided EPS guidance of for the period. The company issued revenue guidance of $70.0 million-$73.0 million, compared to the consensus revenue estimate of $66.5 million.

What is Lynne Laube's approval rating as Cardlytics' CEO?

26 employees have rated Cardlytics Chief Executive Officer Lynne Laube on Glassdoor.com . Lynne Laube has an approval rating of 86% among the company's employees. 61.0% of employees surveyed would recommend working at Cardlytics to a friend.

What other stocks do shareholders of Cardlytics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardlytics investors own include NVIDIA (NVDA) , Block (SQ) , DocuSign (DOCU) , Advanced Micro Devices (AMD) , Caterpillar (CAT) , Walt Disney (DIS) , Alibaba Group (BABA) , Trade Desk (TTD) , QUALCOMM (QCOM) and Twilio (TWLO) .

When did Cardlytics IPO?

Cardlytics (CDLX) raised $76 million in an initial public offering on Friday, February 9th 2018. The company issued 5,400,000 shares at $13.00-$15.00 per share. BofA Merrill Lynch and J.P. Morgan served as the underwriters for the IPO and Wells Fargo Securities, SunTrust Robinson Humphrey, Raymond James and KeyBanc Capital Markets were co-managers.

Who are Cardlytics' major shareholders?

Cardlytics' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Los Angeles Capital Management LLC (0.24%). Insiders that own company stock include Amit Gupta, Andrew Christiansen , Clifford Sosin , John V Balen, John V Balen , Karim Saad Temsamani, Kirk Somers , Lynne Marie Laube , Nicholas Hollmeyer Lynton, S Aimee Lapic , Scott D Grimes and Scott D Grimes . View institutional ownership trends .

How do I buy shares of Cardlytics?

Shares of CDLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

Does Cardlytics have any subsidiaries?

The following companies are subsidiares of Cardlytics: Bridg, Cardlytics Services India Private Limited, Cardlytics UK Limited, and DOSH. Read More

NASDAQ:CDLX

Cardlytics (CDLX) Stock Price, News & Analysis

→ This company has increased its dividend every year for 54 years (From DTI) (Ad)

Free CDLX Stock Alerts

$12.18

-0.23 (-1.85%)

(As of 04/17/2024 ET)

Compare

Today's Range: $11.84
▼
$12.59
50-Day Range: $6.25
▼
$20.25
52-Week Range: $4.94
▼
$20.52

Volume: 865,897 shs
Average Volume: 1.59 million shs
Market Capitalization: $586.71 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $15.50

Get Cardlytics alerts:

Cardlytics MarketRank™ Stock Analysis

Analyst Rating: Moderate Buy
2.75 Rating Score
Upside/Downside: 27.3% Upside
$15.50 Price Target
Short Interest: Bearish
12.35% of Shares Sold Short
Dividend Strength: N/A
Sustainability: -0.67
Upright™ Environmental Score
News Sentiment: 0.54
Based on 5 Articles This Week
Insider Trading: Acquiring Shares
$8.96 M Bought Last Quarter
Proj. Earnings Growth: N/A

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.66 out of 5 stars

Business Services Sector

75th out of 297 stocks

Computer Programming, Data Processing, & Other Computer Related Industry

15th out of 59 stocks

3.4

Analyst's Opinion

Consensus Rating
Cardlytics has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 3 buy ratings, 1 hold rating, and no sell ratings.
Amount of Analyst Coverage
Cardlytics has only been the subject of 3 research reports in the past 90 days.

2.0

Short Interest

Percentage of Shares Shorted
12.35% of the outstanding shares of Cardlytics have been sold short.
Short Interest Ratio / Days to Cover
Cardlytics has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Cardlytics has recently increased by 32.81%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
Cardlytics does not currently pay a dividend.
Dividend Growth
Cardlytics does not have a long track record of dividend growth.

2.8

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Cardlytics has received a 21.51% net impact score from Upright. Cardlytics seems to create the most significant positive value in categories "Taxes", "Distributing knowledge", and "Jobs". The positive contribution in the "Distributing knowledge" impact category is mostly driven by its "Market intelligence data provision", "Marketing and consumer information services", and "Marketing optimization software" products. See details.
Environmental Sustainability
The Environmental Impact score for Cardlytics is -0.67.

3.1

News and Social Media Coverage

News Sentiment
Cardlytics has a news sentiment score of 0.54. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.43 average news sentiment score of Business Services companies.
News Coverage This Week
MarketBeat has tracked 5 news articles for Cardlytics this week, compared to 2 articles on an average week.
Search Interest
34 people have searched for CDLX on MarketBeat in the last 30 days. This is an increase of 79% compared to the previous 30 days.
MarketBeat Follows
Only 8 people have added Cardlytics to their MarketBeat watchlist in the last 30 days. This is a decrease of -27% compared to the previous 30 days.

3.3

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Cardlytics insiders have bought 1,355.11% more of their company's stock than they have sold. Specifically, they have bought $8,963,613.00 in company stock and sold $616,010.00 in company stock.
Percentage Held by Insiders
Only 0.78% of the stock of Cardlytics is held by insiders.
Percentage Held by Institutions
68.10% of the stock of Cardlytics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.0

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Cardlytics is -3.52, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Cardlytics is -3.52, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Cardlytics has a P/B Ratio of 3.55. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Paradigm Press

AI “wealth window” is closing soon!

Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.

I put together this personal video [HERE]…

About Cardlytics Stock (NASDAQ:CDLX)

Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing. The company was incorporated in 2008 and is headquartered in Atlanta, Georgia.

CDLX Stock Price History

30 days | 90 days | 365 days | Advanced Chart

CDLX Stock News Headlines

April 3, 2024 | insidertrades.com

Cardlytics, Inc. (NASDAQ:CDLX) Insider Nicholas Hollmeyer Lynton Sells 12,460 Shares

March 19, 2024 | insidertrades.com

Insider Buying: Cardlytics, Inc. (NASDAQ:CDLX) Major Shareholder Buys 311,715 Shares of Stock

April 18, 2024 | Priority Gold (Ad)

Biden to Launch “FedNOW” [Move Your Money Now]

Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentially cancel your money. You see Biden and the Fed have teamed up to create a controllable, traceable, programmable digital currency to replace the dollar...

April 17, 2024 | seekingalpha.com

The Power Of Cardlytics' Data Partnerships Including Bank of America

April 15, 2024 | americanbankingnews.com

Cardlytics, Inc. (NASDAQ:CDLX) Short Interest Up 32.8% in March

April 10, 2024 | americanbankingnews.com

Cardlytics (NASDAQ:CDLX) Given New $17.00 Price Target at Needham & Company LLC

April 9, 2024 | globenewswire.com

Liane Hornsey Appointed to Cardlytics Board of Directors

April 9, 2024 | markets.businessinsider.com

Buy Rating Reaffirmed for Cardlytics Amid Growth Prospects and Strategic American Express Partnership

April 18, 2024 | Priority Gold (Ad)

Biden to Launch “FedNOW” [Move Your Money Now]

April 9, 2024 | markets.businessinsider.com

The Analyst Verdict: Cardlytics In The Eyes Of 5 Experts

April 8, 2024 | finance.yahoo.com

Is There An Opportunity With Cardlytics, Inc.'s (NASDAQ:CDLX) 31% Undervaluation?

April 4, 2024 | markets.businessinsider.com

Craig-Hallum Reaffirms Their Buy Rating on Cardlytics (CDLX)

April 3, 2024 | finance.yahoo.com

Cardlytics Inc (CDLX) Chief Legal & Privacy Officer Nicholas Lynton Sells 12,460 Shares

April 3, 2024 | finance.yahoo.com

Cardlytics Inc (CDLX) CEO Karim Temsamani Sells 32,718 Shares

April 2, 2024 | fool.com

Why Cardlytics Stock Skyrocketed 75% Last Month

April 1, 2024 | msn.com

Cliff Sosin Portfolio: Inside the Mind of an Investing Genius

March 27, 2024 | msn.com

Why Cardlytics (CDLX) Stock Is Down 30%

March 27, 2024 | msn.com

Is Cardlytics Stock a Buy After Insider's $13.9M Investment?

March 26, 2024 | globenewswire.com

Cardlytics Prices $150.0 Million Convertible Senior Notes Offering

March 26, 2024 | fool.com

Why Cardlytics Stock Tanked by 33% Today

March 26, 2024 | msn.com

Cardlytics stock dips on proposed $150M convertible notes offering

March 26, 2024 | globenewswire.com

Cardlytics Announces Proposed Convertible Senior Notes Offering

March 24, 2024 | msn.com

Stellantis, Other Beneficial Owners Love These 7 Stocks

March 21, 2024 | finance.yahoo.com

CDLX May 2024 12.500 call

March 20, 2024 | finance.yahoo.com

CDLX Jul 2024 17.500 put

March 18, 2024 | wsj.com

Cardlytics Inc.

March 16, 2024 | seekingalpha.com

Cardlytics, Inc. (CDLX) Q4 2023 Earnings Call Transcript

See More Headlines

Receive CDLX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cardlytics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 3/14/2024
Today: 4/17/2024
Next Earnings (Estimated): 5/02/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Business Services
Industry: Computer programming, data processing, & other computer related
Sub-Industry: N/A
Current Symbol: NASDAQ:CDLX
CUSIP: N/A
CIK: 1666071
Web: www.cardlytics.com
Phone: (888) 798-5802
Fax: N/A
Employees: 434
Year Founded: 2008

Price Target and Rating

Average Stock Price Target: $15.50
High Stock Price Target: $18.00
Low Stock Price Target: $9.00
Potential Upside/Downside: +27.3%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.75
Research Coverage: 4 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($3.46)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-134,700,000.00
Net Margins: -43.56%
Pretax Margin: -43.56%
Return on Equity: -25.38%
Return on Assets: -8.32%

Debt

Debt-to-Equity Ratio: 1.91
Current Ratio: 1.31
Quick Ratio: 1.31

Sales & Book Value

Annual Sales: $309.20 million
Price / Sales: 1.90
Cash Flow: $1.16 per share
Price / Cash Flow: 10.47
Book Value: $3.43 per share
Price / Book: 3.55

Miscellaneous

Outstanding Shares: 48,170,000
Free Float: 43,765,000
Market Cap: $586.71 million
Optionable: Optionable
Beta: 1.44

Social Links

13 Stocks Institutional Investors Won't Stop Buying

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

Mr. Karim Temsamani (Age 50)
CEO & Director
Comp: $424.02k
Mr. Nick Lynton
Chief Legal & Privacy Officer and Secretary
Ms. Alexis DeSieno
Chief Financial Officer
Mr. Amit Gupta
COO & GM of Bridg
Mr. Peter Chan
Chief Technology Officer
Mr. Peter Davies
Head of Sales Strategy & Operations
Ms. Carson Napps
Head of People
Mr. Jose Singer
Chief Product Officer
Ms. Evelyne Forester
Chief Business Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

CDLX Stock Analysis - Frequently Asked Questions

Should I buy or sell Cardlytics stock right now?: 4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cardlytics in the last twelve months. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" CDLX shares.
View CDLX analyst ratings or view top-rated stocks.
What is Cardlytics' stock price target for 2024?: 4 brokers have issued 1-year price objectives for Cardlytics' stock. Their CDLX share price targets range from $9.00 to $18.00. On average, they predict the company's stock price to reach $15.50 in the next twelve months. This suggests a possible upside of 27.3% from the stock's current price.
View analysts price targets for CDLX or view top-rated stocks among Wall Street analysts.
How have CDLX shares performed in 2024?: Cardlytics' stock was trading at $9.21 at the beginning of the year. Since then, CDLX shares have increased by 32.2% and is now trading at $12.18.
View the best growth stocks for 2024 here.
Are investors shorting Cardlytics?: Cardlytics saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 5,950,000 shares, an increase of 32.8% from the March 15th total of 4,480,000 shares. Based on an average daily trading volume, of 1,680,000 shares, the short-interest ratio is presently 3.5 days.
View Cardlytics' Short Interest.
When is Cardlytics' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our CDLX earnings forecast.
How were Cardlytics' earnings last quarter?: Cardlytics, Inc. (NASDAQ:CDLX) posted its quarterly earnings data on Thursday, March, 14th. The company reported ($0.14) EPS for the quarter. The company earned $89.17 million during the quarter. Cardlytics had a negative net margin of 43.56% and a negative trailing twelve-month return on equity of 25.38%.
What ETF holds Cardlytics' stock?: Invesco Dorsey Wright Technology Momentum ETF holds 380,072 shares of CDLX stock, representing 1.38% of its portfolio.
What guidance has Cardlytics issued on next quarter's earnings?: Cardlytics updated its first quarter 2024 earnings guidance on Thursday, March, 14th. The company provided EPS guidance of for the period. The company issued revenue guidance of $70.0 million-$73.0 million, compared to the consensus revenue estimate of $66.5 million.

What is Lynne Laube's approval rating as Cardlytics' CEO?: 26 employees have rated Cardlytics Chief Executive Officer Lynne Laube on Glassdoor.com. Lynne Laube has an approval rating of 86% among the company's employees. 61.0% of employees surveyed would recommend working at Cardlytics to a friend.
What other stocks do shareholders of Cardlytics own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Cardlytics investors own include NVIDIA (NVDA), Block (SQ), DocuSign (DOCU), Advanced Micro Devices (AMD), Caterpillar (CAT), Walt Disney (DIS), Alibaba Group (BABA), Trade Desk (TTD), QUALCOMM (QCOM) and Twilio (TWLO).
When did Cardlytics IPO?: Cardlytics (CDLX) raised $76 million in an initial public offering on Friday, February 9th 2018. The company issued 5,400,000 shares at $13.00-$15.00 per share. BofA Merrill Lynch and J.P. Morgan served as the underwriters for the IPO and Wells Fargo Securities, SunTrust Robinson Humphrey, Raymond James and KeyBanc Capital Markets were co-managers.
Who are Cardlytics' major shareholders?: Cardlytics' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Los Angeles Capital Management LLC (0.24%). Insiders that own company stock include Amit Gupta, Andrew Christiansen, Clifford Sosin, John V Balen, John V Balen, Karim Saad Temsamani, Kirk Somers, Lynne Marie Laube, Nicholas Hollmeyer Lynton, S Aimee Lapic, Scott D Grimes and Scott D Grimes.
View institutional ownership trends.
How do I buy shares of Cardlytics?: Shares of CDLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.
Does Cardlytics have any subsidiaries?: The following companies are subsidiares of Cardlytics: Bridg, Cardlytics Services India Private Limited, Cardlytics UK Limited, and DOSH.
Read More

This page (NASDAQ:CDLX) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial